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Abstract
Objective: To analyze the relationship of depressive symptoms with differentiated components of cognitive function in
older adults using the Neuronorma.Co protocol. Methodology: We analyzed the cognitive performance of 144 adults,
58.3% women, with an average age of 68.1±11.2 years. A factor analysis of main components was performed to
identify independent factors of cognitive function. Multiple linear regression analysis was used to estimate the type and
strength of association between depressive symptoms and neurocognitive performance components. Results: Seven
differentiated components of cognitive performance were identified. In the multivariate analysis, interference control
and language were affected by the total score on the Yesavage Geriatric Depression Scale. Conclusions: The presence
and intensity of depressive symptoms is associated with a lower performance in tasks dependent on executive control.
Resumen
Objetivo: Analizar la relación de los síntomas depresivos con componentes diferenciados de la función cognitiva de
adultos mayores usando el protocolo Neuronorma.Co. Metodología: Se analizó el rendimiento cognitivo de 144 adultos,
58,3% mujeres, con una edad media de 68,1±11,2 años. Se realizó un análisis factorial de componentes principales,
para identificar factores independientes de la función cognitiva. Se usó el análisis de regresión lineal múltiple para
estimar el tipo y la fuerza de asociación entre síntomas depresivos y los componentes del desempeño neurocognitivo.
Resultados: Se identificaron siete componentes diferenciados del rendimiento cognitivo. En el análisis multivariado
el control de la interferencia y el lenguaje resultaron afectados por la puntuación total en la Escala de Depresión
Geriátrica de Yesavage.
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1. Introduction
Exploring the relationship between depression and cog-
nitive performance is relevant when dealing with factors
associated with normal and pathological aging. It has
been established that, in older population, depression
is a risk factor for cognitive deterioration (Roca Socar-
rás & Henriette, 2012; Steenland et al., 2012). Fur-
thermore, for those who already have mild cognitive
impairment (MCI), depressive disorder is a worsening
factor (Gabryelewicz et al., 2007). The causal relation-
ship between depression and neurodegenerative diseases
seems to be clear. A meta-analysis of longitudinal stud-
ies established that depression nearly doubles the risk
of cognitive deterioration (Gao et al., 2013). It is also
known that the more depressive episodes, the greater the
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risk of dementia (Da Silva, Goncalves-Pereira, Xavier,
& Mukaetova-Ladinska, 2013). Another evidence favor-
ing this hypothesis is the results of large databases of
records of psychiatric cases in Scandinavian countries,
which shows how the use of antidepressants leads to a
lower incidence of dementia (Kessing, Sondergard, For-
man, & Andersen, 2009).
A close relationship has also been found between the
appearance of depressive symptoms, the reduction of
cognitive capacity, and the presence of chronic diseases,
like cerebrovascular diseases, hypertension, diabetes, can-
cer, and chronic obstructive pulmonary disease—condi-
tions that are highly prevalent in older people (Alvarán,
Gómez, Aguirre, & Ortiz, 2008; Kirkman et al., 2012;
López Torres et al., 2014; Roca Socarrás & Henriette,
2012; Smith & Blumenthal, 2011; Stanley, 2014).
Depressive symptoms are the most common neuropsy-
chiatric symptoms in MCI, and can be considered as a
transition state between normal cognition and dementia.
Several studies have established a significant relation-
ship between the severity of depressive symptoms and
the deterioration of cognitive functions (Spira, Rebok,
Stone, Kramer, & Yaffe, 2012). Some meta-analyses have
also determined that depressive patients show alterations
in executive functions (EFs) and the working memory,
which has collateral effects on other cognitive domains
(Bora, Harrison, Yücel, & Pantelis, 2013; Rock, Roiser,
Riedel, & Blackwell, 2014; Snyder, 2014).
Other studies have explored the effect of depressive
symptoms as risk factors (Dotson, Beydoun, & Zonder-
man, 2010; Ownby, Crocco, Acevedo, John, & Loewen-
stein, 2006) and even as prodromes of cognitive impair-
ment (Dotson et al., 2010), and have proposed that the
reduction of depressive symptoms decreases the risk of
deterioration progression (Steenland et al., 2012).
Furthermore, a longitudinal study with 562 people
aged 65–85 years examined the relationship of depressive
symptoms with the diagnosis of cognitive impairment
and dementia, to determine whether these symptoms
predict continuous cognitive deterioration. After a three-
year follow-up, researchers did not obtained results that
supported this idea (Neubauer, Wahl, & Bickel, 2013).
Probably, the use of nonspecific tools to detect cognitive
impairment in early stages, like the Mini-Mental State
Examination used in this study, explains these negative
results.
It can be assumed that there is a dimensional rela-
tionship between the appearance of depressive symptoms
and cognitive deterioration. Empirical evidence suggests
that depression is a risk factor and a prodrome of MCI
and dementia (Kessing, 2012). Moreover, it has been
determined that an appropriate treatment of depression
can mitigate the burden of dementia (Steenland et al.,
2012).
In Colombia, studies evidence the need to charac-
terize the effects of depressive symptoms on cognitive
performance, taking into account moderating factors
such as habits and medical history. This relationship
should also be explored using measurements adapted
and validated for our population, since it is usual to use
scales designed for other populations. Thus, the purpose
of this study was to analyze the relationship between
depressive symptoms and differentiated components of
the cognitive function in older people, using a neuropsy-
chological assessment battery adapted and validated in
the Colombian population.
2. Method
2.1 Participants
The study included 144 adults over the age of 49, se-
lected through non-probabilistic sampling. Subjects who
fulfilled the requirements to participate were identified
using the snowball technique; and they, in turn, helped
locate other participants with similar characteristics.
Most of the subjects were invited to the study by the
members of the NEUROPSIS undergraduate research
group, from the School of Psychology of Universidad de
San Buenaventura (Medellín), who explained to their rel-
atives and acquaintances the objective of the study and
put them in contact with the researchers for evaluation.
This mechanism resulted in a sample that included em-
ployees of the university, relatives of the research group
members, and older people who were part of senior clubs,
attended day care centers, or resided in assisted living
facilities.
The study excluded those people with pathology of
the central nervous system that could affect cognition,
other than a MCI caused by a possible process of de-
mentia; unstable or clinically significant cardiovascular
disease within 6 months prior to the evaluation; or his-
tory of alcohol or drug abuse within 24 months prior to
the evaluation.
2.2 Measures
The Subjective Memory Complaints scale (Hernández,
Montañés, Gámez, Cano, & Núñez, 2007) was used to
select and classify the participants, and the Geriatric
Depression Scale (Yesavage et al., 1982) was applied to
evaluate current depression. In addition, all participants
were asked for sociodemographic information, personal
health history, habits, and use of medicines.
The evaluation of cognitive performance was con-
ducted using Neuronorma.Co—a neuropsychological as-
sessment battery adapted and validated for Colombia
by Patricia Montañés’ team at Universidad Nacional de
Colombia (Montañés, 2016). In Colombia, normative
data were calculated for ten age groups and according to
the effect of sociodemographic variables such as schooling
and sex, given the broad spectrum of the population that
ranges from functional illiterate people to people with
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postgraduate studies. The use of the normative data
obtained from such a diverse sample favors the reliability
of the diagnoses in Colombia, as well as the unification of
criteria for interpreting tests. This battery has exhibited
good psychometric properties for the evaluation of this
population and has been used in other studies in the
country (Duarte, Espitia, & Montañés, 2016).
The Neuronorma.Co battery tasks used in this re-
search to evaluate the cognitive functions were: 1) Digit
Span Task (backward and forward) from the WAIS-III;
2) Trail Making Test (parts A and B; 3) Symbol Digit
Modalities Test; 4) Visuospatial Span Task (forward and
backward Corsi Blocks Test) (Peña Casanova, Quiñones
Úbeda, et al., 2009c); Boston Naming Test; 6) Token
Test (Peña Casanova, Quiñones Úbeda, et al., 2009a);
7) Rey–Osterrieth Complex Figure (Copy and Recall)
(Peña Casanova, Gramunt-Fombuena, et al., 2009); 8)
Learning and Memory Task with Controlled Encoding
(Hernández et al., 2007); 9) Wisconsin Card Sorting Test
(Grant & Berg, 1948); 10) Tower of London Test; 11)
Stroop Color and Word Test (Peña Casanova, Quiñones
Úbeda, et al., 2009b); 12) Verbal Fluency Task (Isaacs
& Kennie, 1973); and 13) Phonological Fluency Task
(Borkowski, Benton, & Spreen, 1967).
2.3 Procedure
This research was approved by the Bioethics Institu-
tional Committee of Universidad de San Buenaventura,
Medellín. Once the evaluator explained the details of
the study, each participant signed a written informed
consent. Subsequently, the evaluation was conducted in
two sessions: the clinical scales and the attention and
memory tasks were applied in the first session, while the
second session consisted of tasks related to visuospatial
abilities, language, and EFs from the Neuronorma.Co
battery.
The staff that conducted the evaluations and partici-
pated in the edition and storage of the data was trained
for applying the protocol. Special emphasis was placed
on the study of handbooks, videos, and materials re-
quired in each neuropsychological or psychological test.
A database was designed in Microsoft Access 2016 for
storing the data obtained. Direct scores were included
along with scalar scores categorized by age and schooling
in the Colombian sample (Montañés, 2016), the latter
scores being preferred in the analyses. Once collected,
the data were exported to the SPSS 23.0 software for
statistical treatment.
2.4 Data analysis
Performance in the Neuronorma.Co battery, in the clini-
cal scales, and in the screening tools is expressed in aver-
age scores and standard deviations. As for the categorical
variables, their frequencies are described in percentage
terms.
To identify factors that do not depend on cognitive
functioning, an exploratory factor analysis (EFA) of the
scalar scores obtained in the tasks that make up the
Neuronorma.Co battery was carried out through a prin-
cipal component analysis (PCA) with orthogonal rotation
(varimax). To determine the number of factors to be kept,
the following criteria were considered: eigenvalues should
be greater than 1 and derived from each component, the
factors kept should explain at least 60% of the variance
and, finally, each factor should have at least three vari-
ables with significant factor weights. A standard score
for each subject was generated by calculating the average
scalar performance in the set of neuropsychological tasks
of each component.
Spearman’s correlation coefficients were examined
to identify the correlations between the total score in
the Yesavage Geriatric Depression Scale and the stan-
dard scores in each component obtained from the Neu-
ronorma.Co neuropsychological battery. The Mann–Whit-
ney U test was used to analyze the relationship of cogni-
tive performance with dichotomous categorical variables.
Finally, the type and strength of the relationship
between depressive symptoms and cognitive performance
were estimated using multiple linear regression models.
Every equation included the parameters of interest, that
is the score obtained in each cognitive component as a
dependent variable, and the independent variables, such
as the total score in the Yesavage Depression Scale, the
years of schooling, and each of the covariates relevant to
the bivariate analysis. The Backward method was used
to select the variables in the final model. A significance
level of 𝑝 < 0.05 was assumed for all contrasts.
3. Results
Table 1 summarizes the sociodemographic and clinical
characteristics of the participants.
Table 2 shows the mean scores and standard devia-
tions that reflect the performance in the Neuronorma.Co
battery.
3.1 Factor analysis
The PCA with varimax rotation included 29 standardized
measures collected from 14 neuropsychological tests. The
overall measure of sampling adequacy was appropriate
(KMO=0.807). The Bartlett’s test of sphericity 𝜒2(406) =
2,085.94 𝑝 < 0.001 indicates that the correlation between
the variables was strong enough for the PCA.
Seven factors with eigenvalues greater than 1 were
extracted; their combination explained 68.36% of the vari-
ance (Table 3). The first factor groups tasks associated
with memory functioning; the second factor displays the
performance in tasks typically related to interference con-
trol or inhibitory control; the third component consists of
variables that account for the performance in categoriza-
tion and flexibility processes; the fourth factor groups
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Table 1
Sociodemographic and clinical characteristics of the sample.
𝑁 %
Sex
Man 60 41.7
Woman 84 58.3
Education
Illiterate 4 2.8
Primary education (unfinished) 32 22.2
Primary education 7 4.9
Secondary education (unfinished) 24 16.7
Secondary education 19 13.2
Associate degree 27 18.8
Higher education 31 21.5
Bilingualism
Yes 21 14.6
Marital status
Married 45 31.3
Separated/Divorced 32 22.2
Single 40 27.8
Widowed 27 18.8
Habits
Coffee consumption 106 74.1
Alcohol consumption 16 11.3
Tobacco consumption 18 13.7
Personal medical history
Hypertension 53 37.1
Dyslipidemia 53 37.1
Diabetes 14 9.8
Thyroid disease 25 17.5
Medication
Antidepressants 16 11.1
Anxiolytics 5 3.5
Neuroleptics 3 2.1
Anti-dementia drugs 10 6.9
Antiplatelets 9 6.3
Antiarrhythmics 2 1.4
𝑀±𝑆𝐷
Age 68.11±11.2
Years of schooling 10.4±5.5
Total memory complaints 12.9±8.4
Total Yesavage scale 2.35±2.7
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Table 2
Descriptive statistics of the scalar scores obtained in the neuropsychological battery applied to 144 adults.
𝑀 𝑆𝐷 𝑀𝑖𝑛𝑖𝑚𝑢𝑚𝑀𝑎𝑥𝑖𝑚𝑢𝑚
Forward Verbal Span 11.01 2.49 4 18
Backward Verbal Span 10.99 2.89 6 18
Forward Visuospatial Span© 10.73 2.95 5 18
Backward Visuospatial Span© 10.83 3.31 5 18
Trail Making Test A 9.1 2.89 2 16
Trail Making Test B 9.1 2.87 2 16
SDMTc© 9.66 2.94 3 18
Boston Naming Test© 8.53 3.41 2 18
Token Test 8.73 3.5 2 18
ROCF (Copy) 9.15 4.03 2 18
ROCF (Recall) 10.61 2.15 6 16
FCSRT (Free recall – Trial 1) 8.64 3.58 2 18
FCSRT (Total free recall) 7.67 3.75 2 18
FCSRT (Total recall) 7.32 3.9 2 18
FCSRT (Delayed free recall) 7.23 3.44 2 18
FCSRT (Delayed total recall) 7.75 5.28 2 18
ROCF (Immediate recall – 3 minutes) 7.93 3.44 2 17
Semantic verbal fluency 8.87 3.34 2 18
Phonemic verbal fluency (p) 9.58 2.96 2 18
Stroop Test© (Word) 8.31 3.14 2 15
Stroop Test© (Color) 9.01 3.45 2 18
Stroop Test© (Word-Color) 9.01 3.34 2 17
Stroop Test© (Interference) 8.46 3.26 1.5 16.41
TOL-DX© (Total correct) 10.08 3.03 2 17
TOL-DX© (Total moves) 9.14 3.28 2 18
TOL-DX© (Initiation time) 9.48 3.98 2 18
TOL-DX© (Execution time) 8.83 3.72 2 18
TOL-DX© (Total time) 9.15 3.81 2 18
WCST-M (Categories completed) 9.94 3 3 18
WCST-M (Perseverative errors) 9.31 3.43 3 19
WCST-M (Correct answers) 9.13 3.32 2 18
WCST-M (Attentional failures) 14.51 4.73 3 18
Note: SDMTC©= Symbol Digit Modalities Test; ROCF = Rey–Osterrieth Complex Figure; FCSRT = Free
and Cued Selective Reminding Test - Immediate Recall; TOL-DX© = Tower of London; WCST-M = Wisconsin
Card Sorting Test (Modified).
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Table 3
Summary of the results of the factor analysis for the scalar scores in neuropsychological tests (𝑛 = 111).
Rotated factor loadings
F1 F2 F3 F4 F5 F6 F7
FCSRT (Total free recall) 0.902
FCSRT (Total recall) 0.877
FCSRT (Delayed free recall) 0.845
FCSRT (Free recall – Trial 1) 0.778
FCSRT (Delayed total recall) 0.774
ROCF (Immediate recall – 3 minutes) 0.551
Stroop Test© (Interference) 0.815
Stroop Test© (Word-Color) 0.783
Stroop Test© (Color) 0.736
Stroop Test© (Word) 0.64
SDMTc© 0.515
Trail Making Test B 0.41
WCST-M (Correct answers) 0.903
WCST-M (Categories completed) 0.832
WCST-M (Perseverative errors) 0.762
Phonemic verbal fluency (p) 0.651
Backward Verbal Span 0.625
Forward Verbal Span 0.62
Token Test 0.605
Boston Naming Test© 0.477
Backward Visuospatial Span© 0.753
Forward Visuospatial Span© 0.586
ROCF (Copy) 0.416
ROCF (Recall) 0.779
Trail Making Test A 0.666
Semantic verbal fluency 0.617
TOL-DX© (Total time) 0.864
TOL-DX© (Execution time) 0.85
TOL-DX© (Initiation time) 0.528
Eigenvalues 9.25 3.38 1.9 1.43 1.42 1.23 1.2
% of variance 14.97 12.23 9.09 8.89 7.93 7.68 7.54
Cronbach’s 𝛼 0.9 0.89 0.85 0.81 0.7 0.65 0.81
Standard score M±SD 7.7±3.2 8.8±2.6 9.4±2.8 9.7±2.3 10.2±2.7 9.5±2.2 9.1±3.2
Note: The table only shows the significant factor loadings (equal to or greater than 0.375). The Cronbach’s coefficient 𝛼 for
each factor has been calculated based on the items with a factor loading > 0.375.
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tasks that show the performance in language; the fifth
factor describes the performance in visuospatial planning;
the sixth factor accounts for the processing speed; and,
finally, the seventh component contains the processes
required for planning (Tirapu-Ustárroz, Cordero-Andrés,
Luna-Lario, & Hernáez-Goñi, 2017).
A standard score corresponding to the average scalar
score obtained from the variables grouped in each factor
was generated for each subject (Table 3). Since these
values reflect accurately the structure of the factor, they
were used in the subsequent analysis.
3.2 Correlations between depressive symptoms and
scores in cognitive factors
A correlation analysis was performed to observe the
influence of age and schooling, besides the total score,
on the Yesavage Geriatric Depression Scale, through a
Spearman’s rank correlation coefficient (𝜌). The results
are shown in Table 4.
The relationships between the cognitive factors and
the variables related to habits and medical history were
examined using the Mann–Whitney U test. It was found
that memory tasks are affected by tobacco consumption
(𝑈 = 615; 𝑝 < 0.01), drug abuse (𝑈 = 1.5; 𝑝 < 0.05), use
of antiarrhythmic drugs (𝑈 = 26.5; 𝑝 < 0.05), and use of
anti-dementia drugs (𝑈 = 179.5; 𝑝 < 0.001).
The performance in visuospatial tasks is also different
in men and women (𝑈 = 1975; 𝑝 < 0.05), and varies in
tobacco users (𝑈 = 619; 𝑝 < 0.01) and individuals with
history of hypertension (𝑈 = 1789; 𝑝 < 0.05). These abil-
ities are also affected by the use of antiplatelets (𝑈 = 278;
𝑝 < 0.01), anxiolytics (𝑈 = 108; 𝑝 < 0.01), and neurolep-
tics (𝑈 = 31; 𝑝 < 0.05). Tobacco consumption also inter-
venes in the processing speed (𝑈 =675; 𝑝 < 0.05). Finally,
sex (𝑈 = 1377; 𝑝 < 0.01) and use of anti-dementia drugs
(𝑈 = 359; 𝑝 < 0.05) have an impact on planning.
3.3 Multiple regression analysis
In the multiple regression analysis, each cognitive com-
ponent was examined separately.
For the memory component, the multiple regression
coefficient of the model (𝑅) was 0.511; the adjusted
𝑅2 (coefficient of determination) was 0.237; the level
of significance of the 𝐹 test (10.843) in the analysis of
variance was 𝑝 < 0.001; the 𝛽 values, that indicate the
intensity of the effect of each variable of the final model,
were 𝛽 = 0.285, 𝑝 = 0.001 for years of schooling and
𝛽 = −0.298, 𝑝 < 0.001 for the use of acetylcholinesterase
inhibitors. Depressive symptoms do not affect the vari-
ance of the scores obtained in this ability (𝛽 = −0.003,
𝑝 = 0.971).
In inhibitory control, the coefficient R was 0.542 and
the adjusted 𝑅2 was 0.283. The significance value of
𝐹 (26.667) was 𝑝 < 0.001. The variables with significant
effect on this factor were the total score on the Yesavage
Depression Scale (𝛽 = −0.187, 𝑝 = 0.018) and years of
schooling (𝛽 = 0.451, 𝑝 < 0.001).
Regarding the performance in categorization and
flexibility, only the years of schooling were significant
(𝛽 = 0.291, 𝑝 < 0.001). Although the standardized co-
efficient of the total score in the Yesavage Depression
Scale was negative, it did not reach significant levels
(𝛽 = −0.022, 𝑝 = 0.802). The general parameters of the
model adjusted well: 𝑅= 0.291 and adjusted 𝑅2 = 0.078.
The level of significance of the 𝐹 test (12.123) in the
analysis of variance was 𝑝 = 0.001.
Language was affected by the scores in the Yesavage
Depression Scale (𝛽 = −0.179, 𝑝 = 0.029), the years of
schooling (𝛽 = 0.384, 𝑝 < 0.001), and the use of antiar-
rhythmic drugs (𝛽 = 0.155, 𝑝 = 0.045). In this model,
the value of 𝑅 was 0.518, the adjusted 𝑅2 was 0.251, and
the significance level of the 𝐹 test (15.539) was 𝑝 < 0.001.
The model for the visuospatial planning component
showed good fit indices: 𝑅= 0.546; corrected 𝑅2 = 0.269;
𝐹 statistic=10.443 (𝑝 < 0.001). The 𝛽 values indicate
that the years of schooling (𝛽 = 0.297, 𝑝 < 0.001) improve
the performance of this function, while male sex (𝛽 =
−0.188, 𝑝 = 0.018) seems to be associated with a worse
performance. It is striking that the use of anxiolytics
(𝛽 = −0.180, 𝑝 = 0.023) and neuroleptics (𝛽 = −0.181,
𝑝 = 0.021) is associated with better performance in this
ability. Depressive symptoms were not significant in the
final model (𝛽 = −0.151, 𝑝 = 0.075).
The performance in processing speed was only ex-
plained by the years of schooling (𝛽 = 0.407, 𝑝 = 0.023)
(𝑅 = 0.407; corrected 𝑅2 = 0.159; 𝐹 = 25.64 𝑝 < 0.001).
Lastly, as for the performance in planning, the values
of 𝛽 indicate that the number of years of schooling (𝛽 =
0.285, 𝑝 = 0.001) and the sex (𝛽 = 0.176, 𝑝 = 0.041) are
the variables that explain the percentage of variance of
this ability (𝑅 = 0.357; corrected 𝑅2 = 0.114; 𝐹 = 9.011
𝑝 < 0.001).
4. Discussion
The purpose of this research was to study the relationship
between depressive symptomatology and cognitive per-
formance in older people, taking into account sociodemo-
graphic characteristics, habits, and medical history. The
results obtained show that people with these symptoms
have a reduced cognitive performance in interference
control and language (Spira et al., 2012). This finding
is consistent with other studies that have established
that depressive patients exhibit alterations in EFs and
working memory, hence affecting other cognitive domains
(Bora et al., 2013; Rock et al., 2014; Snyder, 2014).
To explore this idea, it was necessary to analyze the
magnitude, significance, and direction of the Spearman’s
correlation coefficient between the total score in the de-
pression scale and each of the scores in the seven factors,
five of which were inversely associated with depressive
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Table 4
Correlation between age, years of schooling, and total score in the Yesavage Geriatric Depression Scale and the seven
neuropsychological factors in a sample of 144 older adults.
Age Years of schooling Total Yesavage
Memory −0.237∗∗ 0.312∗∗∗ −0.209∗
Inhibitory control −0.213∗ 0.514∗∗∗ −0.279∗∗
Categorization and flexibility −0.246∗∗ 0.293∗∗ −0.1
Language -0.093 0.459∗∗∗ −0.231∗∗
Visuospatial planning −0.280∗∗ 0.407∗∗∗ −0.225∗∗
Processing speed 0.047 0.347∗∗∗ -0.123
Planning −0.289∗∗ 0.314∗∗∗ −0.228∗
Note: 𝜌 = Spearman’s rank correlation coefficient (𝜌). ∗𝑝 < 0.05; ∗∗𝑝 < 0.01; ∗∗∗𝑝 < 0.001.
symptoms: memory, inhibitory control, language, visu-
ospatial planning, and planning. These results coincide
with other studies (Dechent, 2008; Goodale, 2007). How-
ever, in the multivariate analysis, memory, visuospatial
abilities, and planning were not explained significantly
by the variation in depressive symptoms.
Interference control and language kept the significant
association under the statistical control of the covariates
in the multivariate models. These two factors can be
explained from the construct proposed by Stuss (1992),
who defined EFs from a functional perspective as a set of
complementary abilities that make it possible to set and
maintain goals in the working memory, control their exe-
cution, and prevent possible distractions from interfering
with their achievement. The author also proposes an ex-
ecutive functioning model based on the neuroanatomical
location and interconnection of the areas related to EFs
(Stuss, 1992).
The dorsolateral prefrontal cortex (DLPFC) is related
to the most complex cognitive processes (Fuster, 2002).
It is a multimodal association area that integrates in-
formation coming from the unimodal, heteromodal, and
paralimbic association areas—connected to mood. EFs
such as planning, abstraction, working memory, fluency,
complex problem solving, cognitive flexibility, serializa-
tion and sequencing, and organization are attributed to
this area (Alexander & Stuss, 2000). Our results can be
explained in light of these anatomical and functional ob-
servations, given that interference control and language
concentrate tasks that require the optimal performance
of cognitive processes managed by the DLPFC that have
been classified as particularly sensitive to the presence
of depressive symptoms (Alexopoulos, Kiosses, Klimstra,
Kalayam, & Bruce, 2002; Dechent, 2008; Goodale, 2007).
This study found an inverse linear relationship be-
tween the severity of the depressive symptoms and the
visuospatial planning abilities. It has been established
that the difficulties that people with depression exhibit
in processes involving visuospatial planning and ability
to perform cognitive activities that require manipulation
of visual material could be explained by the alteration
in the connection of the DLPFC neural activity (Alexan-
der & Stuss, 2000), in addition to faults in the visual
working memory updating and the spatial and functional
activation that exists in visual and prefrontal areas (Le,
Borghi, Kujawa, Klein, & Leung, 2017).
This suggests that depressive symptoms and cognitive
performance are significantly related, due to the role
of the common mechanism that includes alterations in
visual and prefrontal processing during vision control
and selection and retention of information. Therefore,
the ability to improve the execution of the relevant task
and inhibit nonrelevant information will be affected in
the presence of depressive symptoms (Le et al., 2017).
The results of this study concerning the relationship
between depressive symptoms and performance in in-
terference control can be discussed in the light of the
findings by Hartikainen, Ogawa, and Knight (2012), who
conducted a study in which they found evidence in favor
of the role of emotional modulation in the allocation of
attention resources.
In our study, the tasks grouped in the inhibitory con-
trol factor are closely related to the ability to control the
interference of irrelevant stimuli and the inhibition of re-
sponses in visual processes—something that is negatively
impacted by the presence and intensity of depressive
symptoms. It has been determined that the medial
frontal cortex (MFC) has an influence on processes such
as inhibition, detection and resolution of conflicts, regu-
lation, and attentional effort. It also participates in the
regulation of aggression and motivational states (Fuster,
2002). Therefore, it can be assumed that this area is
involved in the relationship found in this research.
In this regard, a recent study analyzed the functional
consequences of brain changes in depression at a per-
ceptual level, through the observation of a basic visual
process, specifically, the inhibitory process within the
visual motion system called center-surround suppression
(CSS). The authors found that the inhibitory percep-
tual process is altered in currently depressed individuals,
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and that gamma-aminobutyric acid (GABA) depletion
may be responsible for the difficulties in discriminating
the direction of motion under specific conditions (Nor-
ton, McBain, Pizzagalli, Cronin-Golomb, & Chen, 2016).
The above can explain our findings, considering that
low scores in interference control are associated with a
greater presence of depressive symptoms in our sample.
The results of this study also show that schooling
is a relevant variable when analyzing the factors that
affect cognitive performance in older people. However,
it is worth mentioning that there is no consensus in the
literature about the role of schooling in older adults with
depressive symptoms.
On the one hand, some authors, based on the theory
of cognitive reserve, state that schooling is one of the
factors that contributes to the well-being of older adults
and presume that there is no direct relationship between
the severity of a neurological pathology and its effect
on cognitive functioning. Thus, individuals with greater
cognitive reserve will be able to face a more severe pathol-
ogy without their cognitive performance being affected;
contrary to individuals with a reduced reserve, who will
have cognitive alterations in the presence of less severe
pathologies (Stern et al., 2003). Therefore, schooling
is a fundamental aspect in the individual variability of
cognitive reserve (Stern, 2003).
Chen, Copeland, and Wei (1999) point out that low
schooling levels and adverse socioeconomic conditions
are risk factors for depressive disorders in older people.
Similarly, a recent longitudinal study, which monitored
6,220 people from 2002 to 2015, found that belonging
to a low socioeconomic stratum—also associated with
low schooling levels—increases the risk of developing
dementia by a factor of 1.68 (95% CI, 1.05−2.86) (Cadar
et al., 2018).
In conclusion, our study shows that depression is re-
lated to a lower cognitive performance in older adults;
specifically, the presence and intensity of depressive symp-
toms is associated with lower performance in tasks de-
pendent on executive control.
The strengths of our study are related to the speci-
ficity and sensitivity of the instruments used for the
neuropsychological assessment of the sample, since, as
stated by Ismail, Malick, Smith, Schweizer, and Fischer
(2014), when conducting research on the role of depres-
sion in cognitive performance, it is indispensable to use
solid instruments to evaluate all cognitive domains.
Our study is not exempt from limitations. Its transver-
sal design does not allow us to address causal relationship.
This limitation raises the need for longitudinal studies
with appropriate designs and sample sizes to allow re-
searchers to explore this type of relationship. Another
limitation is the implementation of a convenience sam-
pling, which reduces the capacity to make generalizations
about the whole older population. Finally, it is necessary
to perform a more precise measurement of the diagnosis
of depression and a better quantification of its severity
and etiology.
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